Erdem FADİLOĞLU
(Hacettepe Üniversitesi, Perinatoloji Kliniği, Kadın Hastalıkları ve Doğum Anabilim Dalı, Ankara, Türkiye)
Canan ÜNAL
(Hacettepe Üniversitesi, Perinatoloji Kliniği, Kadın Hastalıkları ve Doğum Anabilim Dalı, Ankara, Türkiye)
Atakan TANACAN
(Hacettepe Üniversitesi, Perinatoloji Kliniği, Kadın Hastalıkları ve Doğum Anabilim Dalı, Ankara, Türkiye)
Mehmet Sinan BEKSAÇ
(Hacettepe Üniversitesi, Perinatoloji Kliniği, Kadın Hastalıkları ve Doğum Anabilim Dalı, Ankara, Türkiye)
Yıl: 2020Cilt: 45Sayı: 2ISSN: 2602-3032 / 2602-3040Sayfa Aralığı: 518 - 525İngilizce

117 0
Pregnancy outcomes of patients with rheumatoid arthritis
Purpose: The aim of this studywas to evaluate theobstetric outcomes of women with rheumatoid arthritis(RA)Materials and Methods: This retrospective studyconsisted of 39 women with RA. Patients were evaluatedin terms of seropositivity, having disease >5 years or notand use of any medication.Results: Rate of preterm delivery and intrauterine growthretardation was 33.3% and 21.2%, respectively.Comparisons between seropositive and seronegativewomen did not show any significant difference. Havingdisease more or less than 5 years did not show anysignificant difference in terms of obstetric outcomes.Women with a coexisting disease had a similar rate ofmiscarriage rate compared to remainders (16.6% vs14.8%). Women followed up without any medication hasalso higher rates of miscarriage despite lack of statisticalsignificance.Conclusion: Pregnancies of women with RA must beconsidered as high risk due to increased rates of adversepregnancy outcomes such as preterm delivery andintrauterine growth retardation.
DergiAraştırma MakalesiErişime Açık
  • 1. Tanacan A, Unal C, Yucesoy HM, Duru SA, Beksac MS. Management and evaluation of pregnant women with Takayasu arteritis. Arch Gynecol Obstet. 2019;299:79-88.
  • 2. Tanacan E, Tanacan A, Fadiloglu E, Unal C, Beksac MS. Psoriasis and pregnancy: retrospective evaluation of 47 pregnancies in a tertiary center. Gynecology Obstetrics & Reproductive Medicine. 2019;25:128-32.
  • 3. Hunter TM, Boytsov NN, Zhang X, Schroeder K, Michaud K, Araujo AB. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014. Rheumatol Int. 2017;37:1551-7.
  • 4. Rom AL, Wu CS, Olsen J, Kjaergaard H, Jawaheer D, Hetland ML et al. Fetal growth and preterm birth in children exposed to maternal or paternal rheumatoid arthritis: a nationwide cohort study. Arthritis Rheumatol. 2014;66:3265-73.
  • 5. Ince-Askan H, Dolhain RJ. Pregnancy and rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2015;29:580-96.
  • 6. de Jong PH, Dolhain RJ. Fertility, pregnancy, and lactation in rheumatoid arthritis. Rheum Dis Clin North Am. 2017;43:227-37.
  • 7. Temprano KK, Bandlamudi R, Moore TL. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum. 2005;35:112-21.
  • 8. de Man YA, Dolhain RJ, van de Geijn FE, Willemsen SP, Hazes JM. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008;59:1241-8.
  • 9. De Man YA, Dolhain RJ, Van De Geijn FE, Willemsen SP, Hazes JM. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Care Res. 2008;59:1241-8.
  • 10. van den Brandt S, Zbinden A, Baeten D, Villiger PM, Ostensen M, Forger F. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. Arthritis Res Ther. 2017;19:64.
  • 11. Teitsson I, Withrington R, Seifert M, Valdimarsson H. Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor. Ann Rheum Dis. 1984;43:673-8.
  • 12. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007;146:797-808.
  • 13. Unterscheider J, Daly S, Geary MP, Kennelly MM, McAuliffe FM, O'Donoghue K et al. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. Am J Obstet Gynecol. 2013;208:290.e1-6.
  • 14. Mumusoglu S, Beksac MS, Ekiz A, Ozdemir P, Hascelik G. Does the presence of autoantibodies without autoimmune diseases and hereditary thrombophilia have an effect on recurrent pregnancy loss? J Matern-Fetal Neonatal Med. 2016;29:2352-7.
  • 15. Beksaç K, Örgül G, Çağan M, Karaağaoğlu E, Arslan S, Beksaç MS. Retrospective evaluation of pregnant women with celiac disease. J Turk Ger Gynecol Assoc 2017;18:56-9.
  • 16. Beksac K, Orgul G, Can GS, Oktem A, Kav T, Beksac MS. Management of inflammatory bowel disease and pregnancy using prophylactic low dose low molecular weight heparin and corticosteroids. J Clin Diagn Res. 2017;11(11): QR01-3.
  • 17. Turgal M, Gumruk F, Karaagaoglu E, Beksac MS. Methylenetetrahydrofolate reductase polymorphisms and pregnancy outcome. Geburtshilfe und Frauenheilkunde. 2018;78:871-8.
  • 18. Örgul G, Soyak B, Aydın E, Tanaçan A, Çağan M, Beksaç MS. 22 Haftayı Geçemeyen Gebelikler. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi. 2017;14:66-9.
  • 19. Brouwer J, Laven JS, Hazes JM, Dolhain RJ. Brief report: miscarriages in female rheumatoid arthritis patients: associations with serologic findings, disease activity, and antirheumatic drug treatment. Arthritis Rheumatol. 2015;67:1738-43.
  • 20. Langen ES, Chakravarty EF, Liaquat M, El-Sayed YY, Druzin ML. High rate of preterm birth in pregnancies complicated by rheumatoid arthritis. Am J Perinatol. 2014;31:9-14.
  • 21. Davutoglu EA, Ozel A, Yilmaz N, Madazli R. Pregnancy outcome in 162 women with rheumatic diseases: experience of a university hospital in Turkey. Arch Gynecol Obstet. 2017;296:1079-84.
  • 22. de Man YA, Bakker-Jonges LE, Goorbergh CM, Tillemans SP, Hooijkaas H, Hazes JM, et al. Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy. Ann Rheum Dis. 2010;69:420-3.
  • 23. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116:402-14.
  • 24. Forger F, Villiger PM. Treatment of rheumatoid arthritis during pregnancy: present and future. Expert Rev Clin Immunol. 2016;12:937-44.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.